"The Henry Ford Cancer Institute - Detroit has been designed to deliver an exceptional care experience surrounded in compassion, convenience, innovation, and most importantly, HOPE. Our new cancer pavilion is a global destination site for ambulatory cancer treatment, precision medicine, clinical trials and research, and enhanced cancer support services. Here you'll find one strong, integrated team, ensuring you have access to the latest advances in cancer treatment, research, clinical trials and support for a truly seamless experience at each step of your cancer journey."

During the past decade, Josephine Ford Cancer Center at Henry Ford Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 51 clinical trials were completed, i.e. on average, 221.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Josephine Ford Cancer Center at Henry Ford Hospital" #1 sponsor was "SWOG Cancer Research Network" with 53 trials, followed by "Radiation Therapy Oncology Group" with 32 trials sponsored, "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 12 trials sponsored, "NSABP Foundation Inc" with 11 trials sponsored and "Alliance for Clinical Trials in Oncology" with 11 trials sponsored. Other sponsors include 54 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Josephine Ford Cancer Center at Henry Ford Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 142 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 8 trials as a collaborator. Other collaborators include 37 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Josephine Ford Cancer Center at Henry Ford Hospital" are "Breast Cancer" (27 trials), "Lung Cancer" (23 trials), "Brain and Central Nervous System Tumors" (19 trials), "Prostate Cancer" (15 trials) and "Leukemia" (11 trials). Many other conditions were trialed in "Josephine Ford Cancer Center at Henry Ford Hospital" in a lesser frequency.

Most popular intervention types in "Josephine Ford Cancer Center at Henry Ford Hospital" are "Drug" (132 trials), "Radiation" (62 trials), "Biological" (35 trials), "Procedure" (32 trials) and "Other" (29 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (33 trials), "cisplatin" (15 trials), "cyclophosphamide" (15 trials), "docetaxel" (12 trials) and "adjuvant therapy" (9 trials). Other intervention names were less common.

The vast majority of trials in "Josephine Ford Cancer Center at Henry Ford Hospital" are 133 trials for "All" genders, 28 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Josephine Ford Cancer Center at Henry Ford Hospital". undefined are not yet recruiting, 12 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 123 completed trials in Josephine Ford Cancer Center at Henry Ford Hospital, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Josephine Ford Cancer Center at Henry Ford Hospital, 27 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".